Patents by Inventor Jean-Marie Arlabosse

Jean-Marie Arlabosse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8765805
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radicals of formulae (a)-(c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: July 1, 2014
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Jean-Marie Arlabosse
  • Publication number: 20120214869
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radicals of formulae (a)-(c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions.
    Type: Application
    Filed: April 30, 2012
    Publication date: August 23, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud BIADATTI, Jean-Marie Arlabosse
  • Patent number: 8188106
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radicals of formulae (a)-(c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: May 29, 2012
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Jean-Marie Arlabosse
  • Publication number: 20100273883
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radicals of formulae (a)-(c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions.
    Type: Application
    Filed: July 6, 2010
    Publication date: October 28, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Jean-Marie Arlabosse
  • Patent number: 7767650
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radicals of formulae (a)-(c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: August 3, 2010
    Assignee: Galderma Research & Development
    Inventors: Thibaud Biadatti, Jean-Marie Arlabosse
  • Publication number: 20070117761
    Abstract: Novel ligand compounds having the structural formula (I): in which: Ar is a radical selected from among the radicals of formulae (a)-(c) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, or, alternatively into cosmetic compositions.
    Type: Application
    Filed: June 8, 2006
    Publication date: May 24, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Thibaud Biadatti, Jean-Marie Arlabosse